Brief: Moleculin Announces Pricing Of $4.5 Million Registered Direct Offering And Concurrent Private Placement Priced At-The-Market

Moleculin Biotech

21/12/2023 02:21

Dec 20 (Reuters) - Moleculin Biotech Inc  MBRX.O :
    * MOLECULIN ANNOUNCES PRICING OF $4.5 MILLION REGISTERED
DIRECT
OFFERING AND CONCURRENT PRIVATE PLACEMENT PRICED AT-THE-MARKET
    * MOLECULIN BIOTECH INC - TO PURCHASE 7.04 MILLION SHARES IN
A
REGISTERED DIRECT OFFERING
    * MOLECULIN BIOTECH- ALSO AGREED TO ISSUE UNREGISTERED
WARRANTS TO
PURCHASE UP TO AN AGGREGATE OF 14.09 MILLION SHARES OF COMMON
STOCK
    * MOLECULIN BIOTECH INC - COMBINED EFFECTIVE OFFERING PRICE
IS
$0.64 FOR INSTITUTIONAL INVESTOR, AND $0.69 FOR EXECUTIVE
OFFICERS AND DIRECTORS
    * MOLECULIN BIOTECH INC - WARRANTS WILL HAVE AN EXERCISE
PRICE OF
$0.64 PER SHARE

Source text for Eikon:  ID:nPn5qWxrKa 
Further company coverage:  MBRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))